Boston Research & Management Inc / CL
Boston Research & Management Inc’s Colgate Palmolive Co Position
Does Boston Research & Management Inc own Colgate Palmolive Co (CL)? Yes — 60.7K shares worth $5M (+1.23% of its 13F portfolio) as of Q1 2026, up from 60.1K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
60.7K
% of Portfolio
+1.23%
Quarters Held
29
currently held
Position History CL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 60.7K | $5M | +1.23% |
| Q4 2025 | 60.1K | $5M | +1.09% |
| Q3 2025 | 63.9K | $5M | +1.13% |
| Q2 2025 | 62.9K | $6M | +1.37% |
| Q1 2025 | 63.0K | $6M | +1.47% |
| Q4 2024 | 63.8K | $6M | +1.42% |
| Q3 2024 | 63.2K | $7M | +1.54% |
| Q2 2024 | 62.9K | $6M | +1.54% |
| Q1 2024 | 63.7K | $6M | +1.42% |
| Q4 2023 | 64.0K | $5M | +1.35% |
| Q3 2023 | 61.9K | $4M | +1.30% |
| Q2 2023 | 61.5K | $5M | +1.34% |
| Q1 2023 | 61.4K | $5M | +1.38% |
| Q4 2022 | 61.0K | $5M | +1.49% |
| Q3 2022 | 63.3K | $4M | +1.51% |
| Q2 2022 | 62.9K | $5M | +1.63% |
| Q1 2022 | 62.6K | $5M | +1.38% |
| Q4 2021 | 62.5K | $5M | +1.46% |
| Q3 2021 | 62.1K | $5M | +1.40% |
| Q2 2021 | 59.2K | $5M | +1.46% |
| Q1 2021 | 58.7K | $5M | +1.49% |
| Q4 2020 | 56.2K | $5M | +1.67% |
| Q3 2020 | 56.3K | $4M | +1.70% |
| Q2 2020 | 57.7K | $4M | +1.76% |
| Q1 2020 | 57.5K | $4M | +1.92% |
| Q4 2019 | 58.4K | $4M | +1.51% |
| Q3 2019 | 56.9K | $4M | +1.65% |
| Q2 2019 | 56.1K | $4M | +1.63% |
| Q1 2019 | 56.4K | $4M | +1.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Research & Management Inc’s full portfolio or all institutional holders of CL.